PRESS RELEASE: Director's Dealings announcement according to --15a WpHG (the German Securities Trading Act)

MediGene AG / Director's Dealings announcement according to --15a WpHG (the German Securities Trading Act) . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement.

Details of the person subject to the disclosure requirement Name: Llewellyn-Davies, Peter Person with executive functions: Member of a managing Professional role: body Details of the relationship: CFO

Designation of the financial instrument ISIN: DE0005020903 Designation: Share

Details of the transaction Type of transaction: Purchase Date: 24.06.2013 Place (stock exchange): Tradegate Exchange Price: 0.97 Currency: EUR Quantity: 3500 Business volume: 3395.00

Details of the company with the publishing obligation: Issuer: Medigene AG Lochhamer Strasse 11 D-82152 Martinsried / München Germany ISIN: DE0005020903 WKN: 502090

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the

information contained therein.

Source: Medigene AG via Thomson Reuters ONE

HUG#1712446

--- End of Message ---

Medigene AG

Lochhamer Strasse 11 Martinsried / München Germany

WKN: 502090;ISIN: DE0005020903;

Listed: Freiverkehr in Börse Stuttgart,

Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,

Freiverkehr in Börse Düsseldorf,

Freiverkehr in Bayerische Börse München,

Freiverkehr in Niedersächsische Börse zu Hannover,

Prime Standard in Frankfurter Wertpapierbörse,

Regulierter Markt in Frankfurter Wertpapierbörse;

http://www.medigene.com (END) Dow Jones Newswires

   June 27, 2013 10:48 ET (14:48 GMT)- - 10 48 AM EDT 06-27-13